HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Members Suggest Buying Some Supplements With Pre-Tax Savings

Executive Summary

Eight GOP House members urge IRS to allow supplements labeled with approved health claims to be considered “medical expenses” eligible for payment with pre-tax health savings accounts beginning with tax year 2020.

You may also be interested in...



Making Some Supplements Eligible For US Pre-Tax Savings Accounts Proposed Again In Congress

Dietary supplements would be covered in pre-tax health savings accounts under Senate legislation. Industry groups say the health and economic impact of COVID-19 makes including supplements in the accounts more important. 

Pending US Dietary Guidelines Will Consider Full Life Span, Evaluate Benefits From Supplements

Dietary Guidelines Advisory Committee notes additional guidelines for young children and pregnant women were required by language in the 2014 farm bill. “As a result, this edition will cover the full lifespan.”

COVID-19 Magnifies US Need To Make Supplements Eligible For Pre-Tax Savings – NPA

NPA asks Congress to include supplements in legislation defining "medical expenses” covered by pre-tax health savings accounts. The trade group says industry would prefer supplements were included with OTC drugs in provision in recently passed COVID-19 relief legislation that changed pre-tax account rules.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149422

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel